TY - JOUR
T1 - Can a High-grade Neuroendocrine Carcinoma be Functional?
AU - Graham, Christopher
AU - Chauhan, Aman
AU - Anthony, Lowell
N1 - Publisher Copyright:
© 2018
PY - 2019/3
Y1 - 2019/3
N2 - We present a rare high-grade, functional, neuroendocrine carcinoma of the pancreas secreting vasoactive intestinal peptide. This case is unique, given the tumor's aggressive features and high Ki-67 index while also secreting functional hormones, which is unusual in high-grade neuroendocrine tumors (NETs). Our patient initially presented with diarrhea and was found to have a 4.7 × 3.1 × 3.3 cm pancreatic mass with diffuse hepatic metastasis staining positive for vasoactive intestinal peptide, chromogranin A and synaptophysin. She was initially underscored as grade 2 NET due to low mitosis, but subsequently restaged based on Ki-67 index as a grade 3 neuroendocrine carcinoma. She unfortunately was not a candidate for chemotherapy at that time. We conclude that high-grade NETs have the potential to secrete active peptide hormones. We therefore recommend that NETs with aggressive features be biopsied and assessed for Ki-67 activity and mitosis regardless if they are functional tumors, with goal for early initiation of chemotherapy.
AB - We present a rare high-grade, functional, neuroendocrine carcinoma of the pancreas secreting vasoactive intestinal peptide. This case is unique, given the tumor's aggressive features and high Ki-67 index while also secreting functional hormones, which is unusual in high-grade neuroendocrine tumors (NETs). Our patient initially presented with diarrhea and was found to have a 4.7 × 3.1 × 3.3 cm pancreatic mass with diffuse hepatic metastasis staining positive for vasoactive intestinal peptide, chromogranin A and synaptophysin. She was initially underscored as grade 2 NET due to low mitosis, but subsequently restaged based on Ki-67 index as a grade 3 neuroendocrine carcinoma. She unfortunately was not a candidate for chemotherapy at that time. We conclude that high-grade NETs have the potential to secrete active peptide hormones. We therefore recommend that NETs with aggressive features be biopsied and assessed for Ki-67 activity and mitosis regardless if they are functional tumors, with goal for early initiation of chemotherapy.
KW - Neuroendocrine carcinoma
KW - Neuroendocrine tumor
KW - Vasoactive intestinal peptide
UR - http://www.scopus.com/inward/record.url?scp=85059623620&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85059623620&partnerID=8YFLogxK
U2 - 10.1016/j.amjms.2018.11.001
DO - 10.1016/j.amjms.2018.11.001
M3 - Review article
C2 - 30638597
AN - SCOPUS:85059623620
SN - 0002-9629
VL - 357
SP - 258
EP - 262
JO - American Journal of the Medical Sciences
JF - American Journal of the Medical Sciences
IS - 3
ER -